“
TL;DR
This proof-of-concept clinical study investigated the effect of a seven-day administration of mirtazapine on lipid metabolism in 12 healthy men under standardized conditions.
Naunyn-Schmiedeberg's Archives of Pharmacology · 10 authors, 8 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This proof-of-concept clinical study investigated the effect of a seven-day administration of mirtazapine on lipid metabolism in 12 healthy men under standardized conditions.
This study was an open-label, proof-of-concept clinical trial examining the effects of a seven-day course of mirtazapine 30 mg/day on metabolism in 12 healthy men under highly standardized dietary and activity conditions. The primary finding was that mirtazapine administration led to statistically significant adverse changes in lipid metabolism, including an increase in triglyceride levels and a decrease in HDL-cholesterol, LDL-cholesterol, and total cholesterol. The authors interpret these results as evidence for direct pharmacological effects of mirtazapine on lipid metabolism, independent of weight gain. Limitations include the small sample size, short duration of treatment, lack of a comparator group, and the exploratory, hypothesis-generating nature of the analysis. The findings suggest potential metabolic risks associated with mirtazapine that may be clinically relevant over longer treatment periods or in individuals with pre-existing conditions.